Source: Journal of Pharmacy and Pharmaceutical Sciences. Unidade: FCFRP
Subjects: RUTÊNIO, ÓXIDO NÍTRICO, DOENÇAS CARDIOVASCULARES, FÁRMACOS (SISTEMA CARDIOVASCULAR), SISTEMA RETICULOENDOTELIAL
ABNT
OISHI, Jorge Camargo et al. In vitro treatment with cis-[Ru(H-dcbpy-)2(Cl)(NO)] improves the endothelial function in aortic rings with endothelial dysfunction. Journal of Pharmacy and Pharmaceutical Sciences, v. 18, n. 5, p. 696-704, 2015Tradução . . Disponível em: https://doi.org/10.18433/j3cc9k. Acesso em: 19 nov. 2024.APA
Oishi, J. C., Buzinari, T. C., Pestana, C. R., Moraes, T. F. de, Vatanabe, I. P., Wink Júnior, D. A., et al. (2015). In vitro treatment with cis-[Ru(H-dcbpy-)2(Cl)(NO)] improves the endothelial function in aortic rings with endothelial dysfunction. Journal of Pharmacy and Pharmaceutical Sciences, 18( 5), 696-704. doi:10.18433/j3cc9kNLM
Oishi JC, Buzinari TC, Pestana CR, Moraes TF de, Vatanabe IP, Wink Júnior DA, Silva RS da, Bendhack LM, Rodrigues GJ. In vitro treatment with cis-[Ru(H-dcbpy-)2(Cl)(NO)] improves the endothelial function in aortic rings with endothelial dysfunction [Internet]. Journal of Pharmacy and Pharmaceutical Sciences. 2015 ; 18( 5): 696-704.[citado 2024 nov. 19 ] Available from: https://doi.org/10.18433/j3cc9kVancouver
Oishi JC, Buzinari TC, Pestana CR, Moraes TF de, Vatanabe IP, Wink Júnior DA, Silva RS da, Bendhack LM, Rodrigues GJ. In vitro treatment with cis-[Ru(H-dcbpy-)2(Cl)(NO)] improves the endothelial function in aortic rings with endothelial dysfunction [Internet]. Journal of Pharmacy and Pharmaceutical Sciences. 2015 ; 18( 5): 696-704.[citado 2024 nov. 19 ] Available from: https://doi.org/10.18433/j3cc9k